Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)

BACKGROUND: Renal anemia is an important complication in non-dialysis chronic kidney disease (CKD) patients as well as in dialysis patients. Although recombinant human erythropoietin has dramatically improved prognosis and quality of life in these patients, there have been issues among non-dialysis...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Exp Nephrol
Главные авторы: Kato, Hideki, Nangaku, Masaomi, Hirakata, Hideki, Wada, Takashi, Hayashi, Terumasa, Sato, Hiroshi, Yamazaki, Yasushi, Masaki, Takao, Kagimura, Tatsuo, Yamamoto, Hiroyasu, Hase, Hiroki, Kamouchi, Masahiro, Imai, Enyu, Mizuno, Kyoichi, Iwasaki, Manabu, Akizawa, Tadao, Tsubakihara, Yoshiharu, Maruyama, Shoichi, Narita, Ichiei
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Japan 2017
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805810/
https://ncbi.nlm.nih.gov/pubmed/28660446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-017-1427-4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы